CDC - Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States

	EID Home \| Upcoming Issues and Ahead-of-Print Articles \| Past Issues \| EID Search \| Contact Us *Research* Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States John A. Jernigan,* David S. Stephens,† David A. Ashford, Carlos Omenaca,‡ Martin S. Topiel,§ Mark Galbraith,¶ Michael Tapper,# Tamara L. Fisk,† Sherif Zaki, Tanja Popovic,* Richard F. Meyer,* Conrad P. Quinn,* Scott A. Harper,* Scott K. Fridkin,James J. Sejvar, Colin W. Shepard,* Michelle McConnell,* Jeannette Guarner,* Wun-Ju Shieh,* Jean M. Malecki,** Julie L. Gerberding,* James M. Hughes,* Bradley A. Perkins,* and members of the Anthrax Bioterrorism Investigation Team⁽¹⁾Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Emory University School of Medicine, Atlanta, Georgia, USA; ‡Cedars Medical Center, Miami, Florida, USA; §Virtua Health, Mount Holly, New Jersey, USA; ¶Winchester Medical Center, Winchester, Virginia, USA; #Lenox Hill Hospital, New York City, New York, USA; and *Palm Beach County Department of Public Health, West Palm Beach, Florida, USA

	Back to article Figure 7C. Lymph node from same case shown in B, showing abundant Bacillus anthracis granular antigen staining inside mononuclear inflammatory cells and bacilli (arrows) in the subcapsular hemorrhagic area. (Immunohistochemical assay with a mouse monoclonal anti-B. anthracis cell wall antibody and detection with alkaline phosphatase and naphthol fast red, original magnification 100X)

	Home *\| Top of Page \| Current Issue \| Expedited* \| Upcoming Issue \| Past Issue \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| Search \| Health Topics A-Z** This page last reviewed December 08, 2001 Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention